Eurican DAPPi-Lmulti inj. susp. (lyoph. + susp.) s.c. vial

Pays: Belgique

Langue: anglais

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingrédients actifs:

Canine Distemper Virus (live, attenuated) ; Leptospira Kirschneri Serovar Gryppotyphosa (Inactivated) ; Canine Adenovirus 2 (live, attenuated) ; Leptospira Interrogans Serovar Icterohaemorrhagiae (Inactivated) ; Leptospira Interrogans Serogroup Canicola (Inactivated) ; Canine Parainfluenzavirus (live, attenuated) ; Canine Parvovirus (live, attenuated)

Disponible depuis:

Boehringer Ingelheim Animal Health Belgium SA-NV

Code ATC:

QI07AI02

DCI (Dénomination commune internationale):

Leptospira Interrogans Canicola; Leptospira Interrogans Icterohaemorrhagiae; Leptospira Interrogans Grippotyphosa; Canine Adenovirus Type 2; Canine Distemper Virus (CDV); Canine Parvovirus Type 2; Canine Parainfluenza Virus Type 2

forme pharmaceutique:

Lyophilisate and suspension for suspension for injection

Composition:

Leptospira Interrogans Canicola; Leptospira Interrogans Icterohaemorrhagiae; Leptospira Interrogans Grippotyphosa; Canine Adenovirus Type 2; Canine Distemper Virus (CDV); Canine Parvovirus Type 2; Canine Parainfluenza Virus Type 2

Mode d'administration:

Subcutaneous use

Groupe thérapeutique:

dog

Domaine thérapeutique:

Live Canine Distemper Virus + Live Canine Adenovirus + Live Canine Parainfluenza Virus + Live Canine Parvovirus + Inactivated Leptospira

Descriptif du produit:

CTI code: 480355-02 - Pack size: 25 x 1 dose + 25 x 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 480355-03 - Pack size: 50 x 1 dose + 50 x 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 480355-01 - Pack size: 10 x 1 dose + 10 x 1 ml - Commercialisation status: YES - FMD code: 03661103050094 - CNK code: 3581956 - Delivery mode: Medical prescription

Statut de autorisation:

Commercialised: Yes

Date de l'autorisation:

2015-10-22